Co-Diagnostics, Inc. 8-K

What Happened
Co-Diagnostics, Inc. (CODX) filed a Form 8-K on May 14, 2026 reporting that it issued a press release announcing its financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K and discloses the Company’s use of a non‑GAAP financial measure. The filing also notes Regulation FD disclosure in connection with the release.

Key Details

• Filing date: May 14, 2026; reporting results for quarter ended March 31, 2026.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• Press release includes reference to a non‑GAAP financial measure.
• Form 8-K includes a Regulation FD disclosure (the press release information).

Why It Matters
This filing signals that Co-Diagnostics has publicly released its quarterly performance information; investors should review the Exhibit 99.1 press release for the actual revenue, earnings, cash flow and any non‑GAAP adjustments. The mention of non‑GAAP measures means investors should compare those figures to GAAP results in the company’s periodic filings to fully understand underlying performance.